Navigation Links
Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Date:9/11/2007

a from a cardiovascular outcomes trial in its label.

Given the strength and consistency of the ACTOS data as demonstrated by the prospective studies, meta-analysis, and observational studies, Takeda remains confident in the ACTOS safety profile regarding the risk of macrovascular ischemic events.

About the PROactive Study

The PROactive (PROspective PioglitAzone Clinical Trial In MacroVascular Events) study was a prospective, randomized, placebo-controlled outcomes trial. The study included 5,238 patients with type 2 diabetes and a history of macrovascular disease, who were force titrated up to 45 mg daily of either ACTOS or placebo. In this study, there was no difference in the number of macrovascular events between standard of care and ACTOS, and standard of care alone. Although there was no statistically significant difference between ACTOS and standard of care for the primary endpoint, there was no increase in mortality or total macrovascular events with ACTOS.

The ACTOS Prescribing Information was recently revised by the FDA to include this reassuring cardiovascular safety data making ACTOS the only TZD with safety data from a cardiovascular outcomes trial in its label.

About ACTOS

ACTOS works by directly targeting insulin resistance, a condition in which the body does not efficiently use the insulin it produces to control blood glucose levels. ACTOS is taken once daily as an adjunct to diet and exercise, and is approved for use for type 2 diabetes as monotherapy to lower blood glucose and in combination therapy with insulin, sulfonylureas or metformin.

Important Safety Information About ACTOS

The prescription medication ACTOS is used along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes. ACTOS is taken once daily either alone or in combination with insulin, sulfonylureas, or metformin.

ACTOS is not for everyone. Certain patients with heart failure should not start taking
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab
2. Largest Ever Study of Genetics Behind Common Diseases Published
3. A Just Published Book Promises To Guide Women Regarding Their Frequent UTI’
4. Findings on Dangerous Parasite, Toxoplasma Gondii Published
5. Siddha Medicine Texts to Be Published in English
6. Journal Recommends How To Improve The Performance Of Health Workers
7. Medical Journals should create awareness on Child survival
8. A journal’s report on stress, among pregnant wome
9. Canadian Medical Association Journals Editorial Mess Gets Murkier
10. Journalists Blamed For Bird Flu Spread Across Israel
11. Future of Canadian Medical Association Journal Threatened

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...E, Fla., Nov. 30 The launch of Inv...lability of the first FDA-cleared, fully-automated...is by a radiologist of suspicious breast lesions. ...e Radiological Society of North America 2009 Annua...ip with leading experts in breast MRI, ONCAD for D...
(Date:11/30/2009)...mber 30, 2009 ― Providing free medications t...ients, lives at a relatively low cost for provinci...chers at St. Michael,s Hospital in Toronto. , "...escribed medications because they simply don,t fil... study,s lead author and a physician at St. Michae...
(Date:11/30/2009)...ls improve with specially designed program, study ...s) -- A special, intensive early intervention prog... IQ along with children,s language and social skil...hion, many children are able to learn and make rem...hor of the study, published online Nov. 30 in Pe...
(Date:11/30/2009)...S, N.J., Nov. 30 Kemin Foods, L.C..... and OmniActive Health Technologies, Ltd. ("OmniA...ir dispute. The parties agree that Kemin,s US Pate...ss for Isolation, Purification and Recrystallizati...d Uses Thereof" and the reissues of that patent ar...
(Date:11/30/2009)...R, Calif., Nov. 30 Ameri... ADHC) is pleased to announce the appointment of ...o the Company,s Board of Directors. Mr. McEldowney...iod starting at the Chemical Bank in New York City...etall & McEldowney, San Francisco, an institut...
Breaking Medicine News(10 mins):Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Coverage of inexpensive drugs may increase length and quality of life after heart attack 2Health News:Working Intensely Early on May Help Autistic Kids 2Health News:Working Intensely Early on May Help Autistic Kids 3Health News:Working Intensely Early on May Help Autistic Kids 4Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2
...mple personalized program delivered by mail is mor...mericans struggle to become more physically active...tion can play a crucial role in getting people off...tentially more effective long-term than feedback d...
... astonishing number and variety of microbes, inclu...ns digest food, mitigate disease, regulate fat st...sels. For more than 100 years, scientists have kno... Howard Hughes Medical Institute researchers have ...
...licit Drug Trafficking is a global problem. It has... to a global nuisance, the world would be best wit...oubtedly spurred this nefarious trade, giving rise...der any of these categories - amphetamine-type sti...
...nada-The many survivors of the 2003 epidemic sever...ically but many suffered lingering mental health p...demic Severe Acute Respiratory syndrome (SARS) bec... 800 people around the world, including 44 in Toro...
...e migration of doctors and nurses from the develop...ct on the crisis in health care in poor countries,...ganisation for Economic Cooperation and Developmen...priving poor countries of critically needed health...
...ndreds of Polish nurses who are seeking pay rises ...e on Monday, and warned they would stay put for we...he nurses first pitched camp on a grass verge oppo... they plan to keep up the high-profile protest unt...
Other Medicine News:Health News:Physical Activity can Be Increased by a Motivating Mail 2Health News:Physical Activity can Be Increased by a Motivating Mail 3Health News:Revealing the Secrets of Gut Ecosystem 2Health News:Revealing the Secrets of Gut Ecosystem 3Health News:This 'Grass' is Not Green - Say, 'No Thanks, I Am Fine Without Drugs' 2Health News:This 'Grass' is Not Green - Say, 'No Thanks, I Am Fine Without Drugs' 3Health News:SARS Patients Experience Mental Health Decline 2Health News:Doctor Migration Has Limited Impact on Health Care in Poor Countries: OECD 2Health News:Street-protesting Polish Nurses Threaten to Stay Put 2
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ ...search report is available in its catalogue: ,,..., http://www.reportlinker.com/p0164299/Surgical-I...cal incision closures market holds enormous signif... being performed each year. Surgical disciplines s...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ ...search report is available in its catalogue: ,,...or Balance the Immune Response ,, http://www....herapies-That-Suppress-or-Balance-the-Immune-Respo...y, either attacking an individual body or producin...
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Dr. J...ing and Intervention at George Washington Universi...d how occult lesions identified with Breast-Specif... multi-modality imaging for needle biopsy as well,...nual meeting of the Radiological Society of North ...
Breaking Medicine Technology:Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 2Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 3Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 4Reportlinker Adds Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response 5Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy 2NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 1NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 2NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 3Triage Wireless Inc Becomes Sotera Wireless Inc 6282 1nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 1nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 2
...ical Studies Presented at the Targeted,Anticancer ...ecular,Targets for Cancer Meetings Support Phase 1...20, 2007,/PRNewswire-FirstCall/ -- Sunesis Pharmac...s development-stage compound, SNS-314, at,two lead...ncer,medicines. Findings from in vitro and in vivo...
... published in an upcoming issue of,Anti-Cancer Dru...eutics Inc.,(TSX-V:PRX) today announced that two p...X 302. The Journal of the National Cancer,Institut... Sam,Denmeade and his team at Johns Hopkins Univer...paper describes the Company,s compound,PRX302, wh...
Other Medicine Technology:Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 2Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor,Data Showing Broad Anti-Tumor Activity, Dosing Flexibility 3Protox Announces Publication in Journal of the National Cancer,Institute Supporting PRX302 as Treatment for Prostatic Diseases 2Protox Announces Publication in Journal of the National Cancer,Institute Supporting PRX302 as Treatment for Prostatic Diseases 3
...ourier* controls and monitors the movement of bloo... BloodTrack Courier provides a complete audit trai..., BloodTrack Courier electronically records a...ronment, from its receipt of blood products throug...
...ansconjunctival self-retaining infusion cannulas f...ay provide some benefit to patients that present w...ning the occurrence of suture induced astigmatism....nd does not require a blade for insertion. The reu...
...ent features a smooth, flat tip extending from the...designed tip is used to efficiently chop and manip...r capsule. The end opening port supplies maximum ...ge should the end port become occluded, especially...
... developed and patented a new, smaller and faster ...uted tomography (SPECT) with twice the resolution ...ll as an executive chair, runs on 110 Volts AC and...modeling. The device has no visible moving parts a...
Medicine Products: